白术芍药散治疗溃疡性结肠炎研究进展
|
摘要
溃疡性结肠炎是一种慢性非特异性的复杂性肠道疾病,目前临床治疗以口服西药为主,包括氨基水杨酸、糖皮质激素和免疫抑制剂类,但因其疗效不稳定、毒性大和依赖性强等问题的存在,不适合长期使用。白术芍药散是临床常用的中医传统方剂,具有补脾柔肝和祛湿止泻的功效。现代研究表明,白术芍药散在治疗溃疡性结肠炎方面表现出良好的疗效。该文就白术芍药散治疗溃疡性结肠炎的疗效及作用机制的研究进展进行了综述,并为今后的进一步研究提出了思路和方向。
Ulcerative colitis is a chronic,nonspecific and complex intestinal disease. The current clinical treatment guideline of this disease recommends a variety of options with oral western medicines,such as aminosalicylic acids,glucocorticosteroids,and immunosuppressors. However,due to their unstable therapeutic effects,high toxicities,and strong drug dependence,they are not suitable for long-term administration. Baizhu Shaoyao powder,a traditional Chinese medicinal prescription,is clinically and commonly used for tonifying spleen and softening liver as well as eliminating dampness and relieving diarrhea. Recent researches suggest that Baizhu Shaoyao powder has significant effect in the treatment of ulcerative colitis. This article reviewed the research progress on the curative effect and action mechanism of Baizhu Shaoyao powder in treating ulcerative colitis,and provided the ideas and directions for its further research in future.
Ulcerative colitis is a chronic,nonspecific and complex intestinal disease. The current clinical treatment guideline of this disease recommends a variety of options with oral western medicines,such as aminosalicylic acids,glucocorticosteroids,and immunosuppressors. However,due to their unstable therapeutic effects,high toxicities,and strong drug dependence,they are not suitable for long-term administration. Baizhu Shaoyao powder,a traditional Chinese medicinal prescription,is clinically and commonly used for tonifying spleen and softening liver as well as eliminating dampness and relieving diarrhea. Recent researches suggest that Baizhu Shaoyao powder has significant effect in the treatment of ulcerative colitis. This article reviewed the research progress on the curative effect and action mechanism of Baizhu Shaoyao powder in treating ulcerative colitis,and provided the ideas and directions for its further research in future.
引文
[1]Park S H,Kim Y M,Yang S K,et al.Clinical features and natural history of ulcerative colitis in Korea[J].Inflamm Bowel Dis,2007,13(3):278.
[2]陈锋,严常开.治疗溃疡性结肠炎药物的最新进展[J].世界华人消化杂志,2016,24(12):1840.
[3]王希利,彭艳红,孙明祎,等.中医对溃疡性结肠炎的病因认识[J].辽宁中医杂志,2007,34(5):572.
[4]韦宜宾,刘锟荣,陈国忠.中药治疗溃疡性结肠炎研究进展[J].辽宁中医药大学学报,2015,17(3):222.
[5]王秀珍,郭琳,于永铎.痛泻要方煎剂口服配合保留灌肠治疗肝脾不和型溃疡性结肠炎的疗效观察[J].中国中西医结合消化杂志,2014,22(11):682.
[6]李晟,林振文,朱子奇.白术芍药散联合传统方法治疗溃疡性结肠炎87例[J].海峡药学,2009,21(8):130.
[7]Jeuring S F G,van den Heuvel T R A,Zeegers M P,et al.Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age-an increasing distinct entity?[J].Inflamm Bowel Dis,2016,22(6):1425.
[8]Molodecky N A,Soon I S,Rabi D M,et al.Increasing incidence and prevalence of the inflammatory bowel diseases with time,based on systematic review[J].Gastroenterology,2012,142(1):46.
[9]Scott D A,Martin M.Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases[J].World J Gastroenterol,2006,12(46):7451.
[10]Mc Gilligan V E,Wallace J M W,Heavey P M,et al.Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis[J].Inflamm Bowel Dis,2007,13(1):108.
[11]Andersson R E,Olaison G,Tysk C,et al.Appendectomy and protection against ulcerative colitis[J].The New Engl J Med,2001,344(11):808.
[12]Pallone F,Blanco G D V,Vavassori P,et al.Genetic and pathogenetic insights into inflammatory bowel disease[J].Curr Gastroenterol Rep,2003,5(6):487.
[13]Silverberg M S,Mirea L,Bull S B,et al.A population-and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease[J].Inflamm Bowel Dis,2003,9(1):1.
[14]Satsangi J,Morecroft J,Shah N B,et al.Genetics of inflammatory bowel disease:scientific and clinical implications[J].Best Pract Res Clin Gastroenterol,2003,17(1):3.
[15]Bonen D K,Cho J H.The genetics of inflammatory bowel disease[J].Gastroenterology,2003,124(2):521.
[16]Pastorelli L,Garg R R,Hoang S B,et al.Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis[J].Proc Natl Acad Sci USA,2010,107(17):8017.
[17]Bernardo D,Vallejo-Diez S,Mann E R,et al.IL-6 promotes immune responses in human ulcerative colitis and induces a skinhoming phenotype in the dendritic cells and Tcells they stimulate[J].Eur J Immunol,2012,42(5):1337.
[18]Masuda H,Iwai S,Tanaka T,et al.Expression of IL-8,TNF-alpha and IFN-gamma m-RNA in ulcerative colitis,particularly in patients with inactive phase[J].J Clin Lab Immunol,1995,46(3):111.
[19]Pender S L,Mac Donald T T.Matrix metalloproteinases and the gut-new roles for old enzymes[J].Curr Opin Pharm,2004,4(6):546.
[20]Di Sabatino A,Rovedatti L,Kaur R,et al.Targeting gut T cell Ca2+release-activated Ca2+channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease[J].J Immunol,2009,183(5):3454.
[21]Ohkusa T,Koido S.Intestinal microbiota and ulcerative colitis[J].J Infect Chemother,2015,21(11):761.
[22]周正华.肠道微环境与溃疡性结肠炎[J].世界华人消化杂志,2016,24(11):1695.
[23]Takeuchi O,Hoshino K,Kawai T,et al.Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components[J].Immunity,1999,11(11):4431.
[24]Jobin C,Sartor R B.NF-κB signaling proteins as therapeutic targets for inflammatory bowel diseases[J].Inflamm Bowel Dis,2000,6(3):206.
[25]李冀.方剂学[M].北京:中国中医药出版社,2012:66.
[26]郑礼娟.炮制对白术芍药散化学成分、药动学及药效学影响的研究[D].南京:南京中医药大学,2014.
[27]孙承宽.速祛痛泻酒:中国,101890099A[P].2010-11-24.
[28]郑礼娟,秦昆明,蔡皓,等.多指标正交试验优选白术芍药散提取工艺[J].中国中药杂志,2013,38(10):1504.
[29]Li C Q,He L C,Jin J Q.Atractylenolide I and atractylenolideⅢinhibit lipopolysaccharide-induced TNF-αand NO production in macrophages[J].Phytother Res,2007,21(4):347.
[30]Bose S,Kim H.Evaluation of in vitro anti-inflammatory activities and protective effect of fermented preparations of Rhizoma Atractylodis Macrocephalae on intestinal barrier function against lipopolysaccharide insult[J].Evid Based Complement Alternat Med,2013,2013(2):363076.
[31]He D Y,Dai S M.Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall.,a traditional Chinese herbal medicine[J].Front Pharmacol,2011,2(10):5.
[32]Ho S C,Kuo C T.Hesperidin,nobiletin,and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel(Citri reticulatae pericarpium)[J].Food Chem Toxicol,2014,71:176.
[33]Khan S,Shin E M,Choi R J,et al.Suppression of LPS-induced inflammatory and NF-κB responses by anomalin in RAW 264.7macrophages[J].J Cell Biochem,2011,112(8):2179.
[34]Di Sabatino A,Biancheri P,Rovedatti L,et al.Recent advances in understanding ulcerative colitis[J].Int Emerg Med,2012,7(2):103.
[35]范恒,邱明义,梅家俊,等.理肠四方对溃疡性结肠炎大鼠组织细胞因子TNF-α、IL-6、IL-8、IL-10的影响[J].中医药学刊,2004,22(9):1624.
[36]邱明义,范恒,梅家俊,等.理肠四方对溃疡性结肠炎大鼠结肠组织TNF-αmRNA表达的影响[J].世界华人消化杂志,2004,12(3):706.
[37]朱杭溢,裘生梁,陈武,等.白术水煎液对溃疡性结肠炎大鼠Th细胞相关因子的影响[J].中国中医药科技,2014,21(2):151.
[38]王佐,吴正祥,杨九华,等.白芍总甙对大鼠实验性结肠炎Th17细胞相关因子的作用[J].世界华人消化杂志,2010,18(1):84.
[39]王艳琴,蔺兴遥.陈皮挥发油对溃疡性结肠炎大鼠血清TNF-α及T细胞亚群的影响[J].甘肃中医,2007,20(6):72.
[40]孙静静,邵军军,常惠芸.NF-κB免疫生物学作用的研究进展[J].生物技术通报,2011(11):63.
[41]朱向东,曹燕飞,王燕,等.痛泻要方对溃疡性结肠炎模型大鼠结肠组织中NF-κBp65基因和蛋白表达的影响[J].中国老年学杂志,2014,34(5):1288.
[42]Fang X H,Wu X,Zhu X M,et al.Albiflorin attenuates inflammatory injury by regulating the TLR4 signaling pathway and its negative regulating factor Tollip in experimental modelsofulcerative colitis[J].J Chin Pharm Sci,2016,25(5):366.
[43]Hong S K S,Chaturvedi R,Piazuelo M B,et al.Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity[J].Inflamm Bowel Dis,2010,16(9):1557.
[44]朱向东,曹燕飞,汪斌,等.痛泻要方治疗溃疡性结肠炎模型大鼠的药效学机制[J].中国老年学杂志,2015,35(3):705.
[45]Crespo M E,Gálvez J,Cruz T,et al.Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS[J].Planta Med,1999,65(7):651.
[46]Pavlick K P,Laroux F S,Fuseler J,et al.Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease[J].Free Rad Biol Med,2002,33(3):311.
[47]郭军雄,马丽,王小莲.风药对兔结肠黏膜蛋白与乙酸诱发大鼠溃疡性结肠炎的治疗作用[J].西部中医药,2012,25(3):21.
[48]葛宇黎,霍丽娟,李亮成.黏附分子与溃疡性结肠炎[J].现代中西医结合杂志,2005,14(12):1663.
[49]朱向东,梅晓云,吴红彦,等.痛泻要方对溃疡性结肠炎大鼠结肠黏膜细胞间黏附分子-1 mRNA和蛋白表达的影响[J].中国实验方剂学杂志,2013,19(6):174.
[50]刘喜平,贾育新,吴建军.痛泻要方对溃疡性结肠炎肝郁脾虚证大鼠模型CD44、CD54及CD62P的影响[J].中药药理与临床,2010,26(6):10.
[51]Shama J,Garcia-Medina R,Pouysségur J,et al.Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells[J].Biochem Biophys Res Commun,2008,372(4):845.
[52]Hoffmann M,Kim S C,Sartor R B,et al.Enterococcus faecalis strains differentially regulate Alix/AIP1 protein expression and ERK 1/2 activation in intestinal epithelial cells in the context of chronic experimental colitis[J].J Proteome Res,2009,8(3):1183.
[53]朱向东,段永强,王燕,等.痛泻要方对溃疡性结肠炎大鼠结肠黏膜ERK1、ERK2基因表达的影响[J].南京中医药大学学报,2013,29(4):347.
[54]曹燕飞.疏肝健脾法对溃疡性结肠炎大鼠血清IL-6、IL-10水平及结肠组织Mek1/2基因表达影响的研究[D].兰州:甘肃中医学院,2014.
[55]杜丽娟,唐学贵,李敏.细胞凋亡与溃疡性结肠炎关系的研究进展[J].医学综述,2010,16(24):3702.
[56]范恒,邱明义,梅家俊,等.理肠中药方对溃疡性结肠炎大鼠结肠细胞凋亡及其调控基因表达的影响[J].世界华人消化杂志,2004,12(5):1119.
[57]Cho W S,Chae C.Expression of cyclooxygenase-2 and nitric oxide synthase 2 in swine ulcerative colitis caused by Salmonella typhimurium[J].Veterin Pathol,2004,41(4):419.
[58]方维丽,王邦茂,刘心娟,等.环氧合酶2和前列腺素在溃疡性结肠炎中的作用[J].中华内科杂志,2003,42(9):652.
[59]席向阳.防风对溃疡性结肠炎治疗作用的研究[D].北京:北京中医药大学,2009.
[60]王欣.选择性COX-2抑制剂塞莱昔布(Celecoxib)对大鼠实验性炎症性肠病(IBD)炎症修复的影响[D].上海:同济大学,2006.
[61]Duan S Z,Usher M G,Mortensen R M.PPARs:the vasculature,inflammation and hypertension[J].Curr Opin Nephrol Hypert,2009,18(2):128.
[62]谢勇,周南进,陈江,等.溃疡性结肠炎患者肠黏膜内PPAR-γ和NF-κB p65的表达及意义[C].济南:中华医学会第七次全国消化病学学术会议,2007:692.
[63]朱向东,梅晓云,王燕,等.痛泻要方对溃疡性结肠炎大鼠结肠黏膜PPAR-γ基因和蛋白表达的影响[J].中华中医药杂志,2013,28(4):941.
[64]时军,李昕,张小灵,等.痛泻要方加减防风对实验性UC大鼠结肠黏膜的影响[J].中国实验方剂学杂志,2015,21(4):161.
[65]王喜军.中药血清药物化学[M].北京:科学出版社,2010:72.
[66]孙娟,王键,胡建鹏,等.参苓白术散对脾虚湿困证溃疡性结肠炎大鼠结肠菌群的影响[J].云南中医学院学报,2013,36(4):1.
[67]姚惠,郑培奋,李希诗,等.益气愈溃汤对溃疡性结肠炎IL-33、IL-10及肠道菌群紊乱的纠正作用[J].中华中医药学刊,2013,31(6):1449.
[68]张淼.白术芍药散中陈皮配伍机理研究[D].南京:南京中医药大学,2015.
[69]Bonaz B L,Bernstein C N.Brain-gut interactions in inflammatory bowel disease[J].Gastroenterology,2013,144(1):36.
[70]Ananthakrishnan A N,Khalili H,Pan A,et al.Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis:results from the Nurses'Health Study[J].Clin Gastroenterol Hepatol,2013,11(1):57.
[2]陈锋,严常开.治疗溃疡性结肠炎药物的最新进展[J].世界华人消化杂志,2016,24(12):1840.
[3]王希利,彭艳红,孙明祎,等.中医对溃疡性结肠炎的病因认识[J].辽宁中医杂志,2007,34(5):572.
[4]韦宜宾,刘锟荣,陈国忠.中药治疗溃疡性结肠炎研究进展[J].辽宁中医药大学学报,2015,17(3):222.
[5]王秀珍,郭琳,于永铎.痛泻要方煎剂口服配合保留灌肠治疗肝脾不和型溃疡性结肠炎的疗效观察[J].中国中西医结合消化杂志,2014,22(11):682.
[6]李晟,林振文,朱子奇.白术芍药散联合传统方法治疗溃疡性结肠炎87例[J].海峡药学,2009,21(8):130.
[7]Jeuring S F G,van den Heuvel T R A,Zeegers M P,et al.Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age-an increasing distinct entity?[J].Inflamm Bowel Dis,2016,22(6):1425.
[8]Molodecky N A,Soon I S,Rabi D M,et al.Increasing incidence and prevalence of the inflammatory bowel diseases with time,based on systematic review[J].Gastroenterology,2012,142(1):46.
[9]Scott D A,Martin M.Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases[J].World J Gastroenterol,2006,12(46):7451.
[10]Mc Gilligan V E,Wallace J M W,Heavey P M,et al.Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis[J].Inflamm Bowel Dis,2007,13(1):108.
[11]Andersson R E,Olaison G,Tysk C,et al.Appendectomy and protection against ulcerative colitis[J].The New Engl J Med,2001,344(11):808.
[12]Pallone F,Blanco G D V,Vavassori P,et al.Genetic and pathogenetic insights into inflammatory bowel disease[J].Curr Gastroenterol Rep,2003,5(6):487.
[13]Silverberg M S,Mirea L,Bull S B,et al.A population-and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease[J].Inflamm Bowel Dis,2003,9(1):1.
[14]Satsangi J,Morecroft J,Shah N B,et al.Genetics of inflammatory bowel disease:scientific and clinical implications[J].Best Pract Res Clin Gastroenterol,2003,17(1):3.
[15]Bonen D K,Cho J H.The genetics of inflammatory bowel disease[J].Gastroenterology,2003,124(2):521.
[16]Pastorelli L,Garg R R,Hoang S B,et al.Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis[J].Proc Natl Acad Sci USA,2010,107(17):8017.
[17]Bernardo D,Vallejo-Diez S,Mann E R,et al.IL-6 promotes immune responses in human ulcerative colitis and induces a skinhoming phenotype in the dendritic cells and Tcells they stimulate[J].Eur J Immunol,2012,42(5):1337.
[18]Masuda H,Iwai S,Tanaka T,et al.Expression of IL-8,TNF-alpha and IFN-gamma m-RNA in ulcerative colitis,particularly in patients with inactive phase[J].J Clin Lab Immunol,1995,46(3):111.
[19]Pender S L,Mac Donald T T.Matrix metalloproteinases and the gut-new roles for old enzymes[J].Curr Opin Pharm,2004,4(6):546.
[20]Di Sabatino A,Rovedatti L,Kaur R,et al.Targeting gut T cell Ca2+release-activated Ca2+channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease[J].J Immunol,2009,183(5):3454.
[21]Ohkusa T,Koido S.Intestinal microbiota and ulcerative colitis[J].J Infect Chemother,2015,21(11):761.
[22]周正华.肠道微环境与溃疡性结肠炎[J].世界华人消化杂志,2016,24(11):1695.
[23]Takeuchi O,Hoshino K,Kawai T,et al.Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components[J].Immunity,1999,11(11):4431.
[24]Jobin C,Sartor R B.NF-κB signaling proteins as therapeutic targets for inflammatory bowel diseases[J].Inflamm Bowel Dis,2000,6(3):206.
[25]李冀.方剂学[M].北京:中国中医药出版社,2012:66.
[26]郑礼娟.炮制对白术芍药散化学成分、药动学及药效学影响的研究[D].南京:南京中医药大学,2014.
[27]孙承宽.速祛痛泻酒:中国,101890099A[P].2010-11-24.
[28]郑礼娟,秦昆明,蔡皓,等.多指标正交试验优选白术芍药散提取工艺[J].中国中药杂志,2013,38(10):1504.
[29]Li C Q,He L C,Jin J Q.Atractylenolide I and atractylenolideⅢinhibit lipopolysaccharide-induced TNF-αand NO production in macrophages[J].Phytother Res,2007,21(4):347.
[30]Bose S,Kim H.Evaluation of in vitro anti-inflammatory activities and protective effect of fermented preparations of Rhizoma Atractylodis Macrocephalae on intestinal barrier function against lipopolysaccharide insult[J].Evid Based Complement Alternat Med,2013,2013(2):363076.
[31]He D Y,Dai S M.Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall.,a traditional Chinese herbal medicine[J].Front Pharmacol,2011,2(10):5.
[32]Ho S C,Kuo C T.Hesperidin,nobiletin,and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel(Citri reticulatae pericarpium)[J].Food Chem Toxicol,2014,71:176.
[33]Khan S,Shin E M,Choi R J,et al.Suppression of LPS-induced inflammatory and NF-κB responses by anomalin in RAW 264.7macrophages[J].J Cell Biochem,2011,112(8):2179.
[34]Di Sabatino A,Biancheri P,Rovedatti L,et al.Recent advances in understanding ulcerative colitis[J].Int Emerg Med,2012,7(2):103.
[35]范恒,邱明义,梅家俊,等.理肠四方对溃疡性结肠炎大鼠组织细胞因子TNF-α、IL-6、IL-8、IL-10的影响[J].中医药学刊,2004,22(9):1624.
[36]邱明义,范恒,梅家俊,等.理肠四方对溃疡性结肠炎大鼠结肠组织TNF-αmRNA表达的影响[J].世界华人消化杂志,2004,12(3):706.
[37]朱杭溢,裘生梁,陈武,等.白术水煎液对溃疡性结肠炎大鼠Th细胞相关因子的影响[J].中国中医药科技,2014,21(2):151.
[38]王佐,吴正祥,杨九华,等.白芍总甙对大鼠实验性结肠炎Th17细胞相关因子的作用[J].世界华人消化杂志,2010,18(1):84.
[39]王艳琴,蔺兴遥.陈皮挥发油对溃疡性结肠炎大鼠血清TNF-α及T细胞亚群的影响[J].甘肃中医,2007,20(6):72.
[40]孙静静,邵军军,常惠芸.NF-κB免疫生物学作用的研究进展[J].生物技术通报,2011(11):63.
[41]朱向东,曹燕飞,王燕,等.痛泻要方对溃疡性结肠炎模型大鼠结肠组织中NF-κBp65基因和蛋白表达的影响[J].中国老年学杂志,2014,34(5):1288.
[42]Fang X H,Wu X,Zhu X M,et al.Albiflorin attenuates inflammatory injury by regulating the TLR4 signaling pathway and its negative regulating factor Tollip in experimental modelsofulcerative colitis[J].J Chin Pharm Sci,2016,25(5):366.
[43]Hong S K S,Chaturvedi R,Piazuelo M B,et al.Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity[J].Inflamm Bowel Dis,2010,16(9):1557.
[44]朱向东,曹燕飞,汪斌,等.痛泻要方治疗溃疡性结肠炎模型大鼠的药效学机制[J].中国老年学杂志,2015,35(3):705.
[45]Crespo M E,Gálvez J,Cruz T,et al.Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS[J].Planta Med,1999,65(7):651.
[46]Pavlick K P,Laroux F S,Fuseler J,et al.Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease[J].Free Rad Biol Med,2002,33(3):311.
[47]郭军雄,马丽,王小莲.风药对兔结肠黏膜蛋白与乙酸诱发大鼠溃疡性结肠炎的治疗作用[J].西部中医药,2012,25(3):21.
[48]葛宇黎,霍丽娟,李亮成.黏附分子与溃疡性结肠炎[J].现代中西医结合杂志,2005,14(12):1663.
[49]朱向东,梅晓云,吴红彦,等.痛泻要方对溃疡性结肠炎大鼠结肠黏膜细胞间黏附分子-1 mRNA和蛋白表达的影响[J].中国实验方剂学杂志,2013,19(6):174.
[50]刘喜平,贾育新,吴建军.痛泻要方对溃疡性结肠炎肝郁脾虚证大鼠模型CD44、CD54及CD62P的影响[J].中药药理与临床,2010,26(6):10.
[51]Shama J,Garcia-Medina R,Pouysségur J,et al.Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells[J].Biochem Biophys Res Commun,2008,372(4):845.
[52]Hoffmann M,Kim S C,Sartor R B,et al.Enterococcus faecalis strains differentially regulate Alix/AIP1 protein expression and ERK 1/2 activation in intestinal epithelial cells in the context of chronic experimental colitis[J].J Proteome Res,2009,8(3):1183.
[53]朱向东,段永强,王燕,等.痛泻要方对溃疡性结肠炎大鼠结肠黏膜ERK1、ERK2基因表达的影响[J].南京中医药大学学报,2013,29(4):347.
[54]曹燕飞.疏肝健脾法对溃疡性结肠炎大鼠血清IL-6、IL-10水平及结肠组织Mek1/2基因表达影响的研究[D].兰州:甘肃中医学院,2014.
[55]杜丽娟,唐学贵,李敏.细胞凋亡与溃疡性结肠炎关系的研究进展[J].医学综述,2010,16(24):3702.
[56]范恒,邱明义,梅家俊,等.理肠中药方对溃疡性结肠炎大鼠结肠细胞凋亡及其调控基因表达的影响[J].世界华人消化杂志,2004,12(5):1119.
[57]Cho W S,Chae C.Expression of cyclooxygenase-2 and nitric oxide synthase 2 in swine ulcerative colitis caused by Salmonella typhimurium[J].Veterin Pathol,2004,41(4):419.
[58]方维丽,王邦茂,刘心娟,等.环氧合酶2和前列腺素在溃疡性结肠炎中的作用[J].中华内科杂志,2003,42(9):652.
[59]席向阳.防风对溃疡性结肠炎治疗作用的研究[D].北京:北京中医药大学,2009.
[60]王欣.选择性COX-2抑制剂塞莱昔布(Celecoxib)对大鼠实验性炎症性肠病(IBD)炎症修复的影响[D].上海:同济大学,2006.
[61]Duan S Z,Usher M G,Mortensen R M.PPARs:the vasculature,inflammation and hypertension[J].Curr Opin Nephrol Hypert,2009,18(2):128.
[62]谢勇,周南进,陈江,等.溃疡性结肠炎患者肠黏膜内PPAR-γ和NF-κB p65的表达及意义[C].济南:中华医学会第七次全国消化病学学术会议,2007:692.
[63]朱向东,梅晓云,王燕,等.痛泻要方对溃疡性结肠炎大鼠结肠黏膜PPAR-γ基因和蛋白表达的影响[J].中华中医药杂志,2013,28(4):941.
[64]时军,李昕,张小灵,等.痛泻要方加减防风对实验性UC大鼠结肠黏膜的影响[J].中国实验方剂学杂志,2015,21(4):161.
[65]王喜军.中药血清药物化学[M].北京:科学出版社,2010:72.
[66]孙娟,王键,胡建鹏,等.参苓白术散对脾虚湿困证溃疡性结肠炎大鼠结肠菌群的影响[J].云南中医学院学报,2013,36(4):1.
[67]姚惠,郑培奋,李希诗,等.益气愈溃汤对溃疡性结肠炎IL-33、IL-10及肠道菌群紊乱的纠正作用[J].中华中医药学刊,2013,31(6):1449.
[68]张淼.白术芍药散中陈皮配伍机理研究[D].南京:南京中医药大学,2015.
[69]Bonaz B L,Bernstein C N.Brain-gut interactions in inflammatory bowel disease[J].Gastroenterology,2013,144(1):36.
[70]Ananthakrishnan A N,Khalili H,Pan A,et al.Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis:results from the Nurses'Health Study[J].Clin Gastroenterol Hepatol,2013,11(1):57.